Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J GREENBLATT

Showing results (241-250 of 1,248) with videos related to

Pageof 125
Sort By:
Clinical Pharmacokinetics|May 1, 1986
Drug disposition in obese humans. An updateD R Abernethy, D J Greenblatt
Drug Metabolism Reviews|January 1, 1978
Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerationsD J Greenblatt, R I Shader
Journal of Clinical Psychopharmacology|April 1, 1986
"Look-alikes" and genericsR I Shader, D J Greenblatt
Connecticut Medicine|December 1, 1970
Adverse effects of LSD: a current perspectiveD J Greenblatt, R I Shader
European Journal of Clinical Pharmacology|July 26, 1974
Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: a report from the Boston Collaborative Drug Surveillance ProgramD J Greenblatt, J Koch-Weser
Psychopharmacology Bulletin|April 1, 1979
Pharmacokinetics and clinical drug effects in the elderly [proceedings]R I Shader, D J Greenblatt
The New England Journal of Medicine|October 10, 1974
The archaic barbiturate hypnoticsJ Koch-Weser, D J Greenblatt
JAMA|July 2, 1973
Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance ProgramD J Greenblatt, J Koch-Weser
The Journal of the Maine Medical Association|November 1, 1974
Rational use of psychotropic drugs. IV. AntidepressantsD J Greenblatt, R I Shader
Journal of Clinical Pharmacology|April 18, 2015
American College of Clinical Pharmacology commentary on the Strategic Plan 2010-2014 Progress Report from the Office of Dietary Supplements, National Institutes of HealthDavid J Greenblatt, Raimund M Peter,
Pageof 125

Showing results (241-250 of 1,248) with videos related to

Sort By:
Pageof 125
Clinical Pharmacokinetics|May 1, 1986
Drug disposition in obese humans. An updateD R Abernethy, D J Greenblatt
Drug Metabolism Reviews|January 1, 1978
Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerationsD J Greenblatt, R I Shader
Journal of Clinical Psychopharmacology|April 1, 1986
"Look-alikes" and genericsR I Shader, D J Greenblatt
Connecticut Medicine|December 1, 1970
Adverse effects of LSD: a current perspectiveD J Greenblatt, R I Shader
European Journal of Clinical Pharmacology|July 26, 1974
Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: a report from the Boston Collaborative Drug Surveillance ProgramD J Greenblatt, J Koch-Weser
Psychopharmacology Bulletin|April 1, 1979
Pharmacokinetics and clinical drug effects in the elderly [proceedings]R I Shader, D J Greenblatt
The New England Journal of Medicine|October 10, 1974
The archaic barbiturate hypnoticsJ Koch-Weser, D J Greenblatt
JAMA|July 2, 1973
Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance ProgramD J Greenblatt, J Koch-Weser
The Journal of the Maine Medical Association|November 1, 1974
Rational use of psychotropic drugs. IV. AntidepressantsD J Greenblatt, R I Shader
Journal of Clinical Pharmacology|April 18, 2015
American College of Clinical Pharmacology commentary on the Strategic Plan 2010-2014 Progress Report from the Office of Dietary Supplements, National Institutes of HealthDavid J Greenblatt, Raimund M Peter,
Pageof 125